Apremilast for Erythema Multiforme
NCT05875714
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Erythema Multiforme
Interventions
DRUG:
Apremilast
Sponsor
Robert Micheletti